• Glioma Organoids with Preserved Microenvironment for Drug Te

  2026-05-28

  This study introduces a glioma organoid model that retains the tumor microenvironment, including immune components, from patient-derived tissue. The approach enables more physiologically relevant drug screening and therapeutic evaluation, opening new avenues for personalized treatment strategies.

• Gap26 Connexin 43 Mimetic Peptide: Redefining Pain Pathway R

  2026-05-28

  Explore how Gap26, a potent connexin 43 mimetic peptide, unlocks new advances in neurobiology and pain mechanism research. This article reveals underappreciated mechanistic insights and protocol refinements that distinguish it from standard guides.

• Cy3 NHS Ester (Non-Sulfonated): Protocols and Best Practices

  2026-05-27

  Cy3 NHS ester (non-sulfonated) provides robust, high-sensitivity fluorescent labeling of proteins, peptides, and oligonucleotides, especially where water-insoluble dyes are compatible with the target biomolecule. This dye is best suited for workflows tolerant of organic co-solvents and is not recommended for labeling delicate proteins sensitive to DMSO or DMF.

• Fluorouracil: Optimized Protocols & Troubleshooting in Solid

  2026-05-27

  Fluorouracil (5-Fluorouracil, Adrucil) enables reproducible, high-impact workflows for colon and breast cancer models, with APExBIO providing robust purity and solubility. This guide translates advanced research, including multidrug resistance insights, into actionable protocols and troubleshooting strategies for solid tumor investigations.

• Sodium Dicloxacillin Monohydrate in Advanced MSSA Research

  2026-05-26

  Sodium dicloxacillin monohydrate empowers researchers to interrogate the inhibition of methicillin-sensitive Staphylococcus aureus (MSSA) across both intra- and extracellular environments. This guide details optimized protocols, key innovations, and troubleshooting strategies that maximize data quality in Gram-positive bacterial infection research.

• AO/PI Double Staining Kit: Precision Cell Viability Assays

  2026-05-26

  The AO/PI Double Staining Kit empowers researchers with rapid, multiplexed discrimination of viable, apoptotic, and necrotic cells in complex models. Its dual-dye approach streamlines apoptosis and necrosis detection for advanced workflows, particularly in organoid and cancer research.

• ML385 and NRF2 Inhibition: Expanding Beyond Oncology Researc

  2026-05-25

  Explore ML385 as a selective NRF2 inhibitor, with in-depth analysis of its molecular action, advanced applications, and unique insights into inflammatory bone disease research. This article delivers a deeper, cross-disciplinary perspective on NRF2 signaling pathway inhibition.

• Oligo (dT) 25 Beads: Redefining Eukaryotic mRNA Isolation Fi

  2026-05-25

  Discover how Oligo (dT) 25 Beads harness superparamagnetic technology for unparalleled eukaryotic mRNA isolation. This deep dive reveals their molecular precision, application in complex assays, and how they enable innovation beyond conventional protocols.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-05-24

  The AO/PI Double Staining Kit offers a streamlined, dual-fluorescent approach for distinguishing viable, apoptotic, and necrotic cells in a single workflow. It is suited for researchers needing rapid, reliable cell viability, apoptosis, and necrosis detection across various cell types, but is not intended for applications outside nucleic acid-based viability assessment or for non-fluorescent platforms.

• Sumatriptan’s Anti-Inflammatory Potential: Systematic Review

  2026-05-23

  Ala et al. systematically reviewed the anti-inflammatory actions of sumatriptan, revealing its capacity to modulate key cytokines and inflammatory pathways beyond its established use for migraine. The findings highlight new opportunities for drug repositioning and illuminate potential mechanisms relevant for translational research.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Precision Ad

  2026-05-22

  This review synthesizes recent advances in CXCR4-targeted imaging ligands and therapies for lymphoma, highlighting their dual diagnostic and therapeutic (theranostic) potential. Key innovations include the integration of peptide-based radiotracers and small-molecule antagonists to improve disease localization, prognosis, and response prediction, supporting precision oncology strategies.

• HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis: Precisio

  2026-05-22

  HOBt (1-Hydroxybenzotriazole) stands at the forefront of peptide synthesis, enabling high-fidelity amide bond formation and minimizing epimerization. Discover how APExBIO’s high-purity HOBt streamlines workflows, supports synthesis of complex therapeutics, and offers reproducible results even for challenging substrates.

• Metabolite Regulation of TET2: Protocol Innovations and Impl

  2026-05-21

  Zhang et al. provide a detailed protocol integrating biochemical assays with STD NMR spectroscopy to systematically identify and validate metabolite binding to human TET2 dioxygenase. This work enables high-resolution analysis of activators and inhibitors of TET2, advancing studies on the metabolic-epigenetic interface and its implications for disease models.

• Streptozotocin: Advanced Mechanistic Insights for Diabetes R

  2026-05-21

  Discover how Streptozotocin (STZ) enables precise modeling of β-cell apoptosis and experimental diabetes mellitus induction. This article delivers an in-depth analysis of STZ’s unique mechanisms, protocol optimization, and translational value beyond standard practices.

• Calpain Inhibitor I, ALLN: Workflow Guidance for Apoptosis &

  2026-05-20

  Calpain Inhibitor I, ALLN is a potent and selective inhibitor designed for precise inhibition of calpain and cathepsin proteases in apoptosis assays and ischemia-reperfusion injury models. It is not intended for diagnostic or clinical use, and strict protocol adherence is required to ensure reproducibility and compound stability.

11822 records 4/789 page Previous Next 12345 下5页 Last page